Home » News Update – April 29

    News Update – April 29


    ADRC members Drs. Heather Whitson (Duke), Gwenn Garden (UNC), Carol Colton (Duke) and Rima Kaddurah-Daouk (Duke) were part of research team that published “Infection and inflammation: New perspectives on Alzheimer’s disease” in Brain, Behavior, and Immunity – Health, July 2022.

    Last Call: SLAM-DUNC Abstracts – Deadline: May 3
    The Duke-UNC ADRC is now accepting abstract submissions for the first Symposium for Learning about Alzheimer’s disease-related Medical Research at Duke and UNC, also known as SLAM-DUNC. The symposium, to be held on June 24 – 25 at the Duke Karsh Alumni and Visitors Center, is designed to be a valuable professional development and networking opportunity for early-career investigators from all five partner institutions: Duke, UNC, North Carolina Central University, University of North Carolina at Pembroke, and East Carolina University.

    We would love to see abstracts from all institutions and from a variety of career levels, including undergraduates. Submission deadline is Tuesday, May 3.

    Learn more, register for the event, and submit your abstract >

    Funding Opportunities

    FY22 Peer Reviewed Alzheimer’s Research Program (PRARP) Funding Opportunities

    The PRARP’s mission is to support research to (1) understand the association between traumatic brain injury (TBI) and other military service-related risk factors and Alzheimer’s disease/Alzheimer’s disease-related dementias (AD/ADRD), and (2) improve quality of life and reduce the burden on affected individuals and caregivers for the military, Veterans, and the public.

    For FY22, PRARP is offering three funding mechanisms, summarized below.  Letters of intent (LOIs) are due June 17, 2022, and full applications will be due July 25, 2022.

    • Investigator Initiated Research Award – Supports high impact, high innovation ideas that will contribute to understanding to understanding traumatic brain injury (TBI) and/or military-service-related factors and AD/ADRD research, patient care, and quality of life. There is an early career investigator partnering option (where the early career PI will have their own grant awarded). Investigators at all levels are welcome to apply. Maximum allowable funding for this award is $750,000.
    • Translational Research Award – Supports translational research that will accelerate the movement of promising products and knowledge in AD/ADRD research into clinical applications, including healthcare products and interventions, technologies, behavioral modalities, and/or clinical practice guidelines. This award mechanism supports both preclinical-to-clinical and clinical research-to-clinical care translation. Investigators at all levels are invited to apply. Maximum allowable funding for this award is $1,200,000.
    • Accelerating Diagnostics Research Award – Supports high-impact advancement of robust diagnostic and/or prognostic factors pertaining to AD/ADRD and traumatic brain injury (TBI). Independent investigators at or above the level of Assistant Professor (or equivalent) are invited to apply. Maximum allowable funding for this award is $2,500,000.

    Learn more >

     Neuronal Vulnerability to Proteinopathies in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Not Allowed)
    National Institute on Aging – Division of Neuroscience

    The goal of this Funding Opportunity Announcement (FOA) is to define and characterize neuronal and glial cell populations that are vulnerable to Alzheimer’s disease (AD) and AD-related dementias (ADRD) proteinopathies. The research appropriate to this FOA may seek to:

    • Establish comprehensive sets of data on neuronal and glial cells vulnerable to AD/ADRD proteinopathies based on single-cell transcriptomics or epigenetics signature
    • Identify intrinsic morphological, electrophysiological, and biochemical properties of neurons vulnerable to proteinopathies
    • Identify neural circuits and/or large-scale networks that contribute to vulnerability to proteinopathies

    Learn more >

     Master of Professional Studies in Data Science Fellowship
    Center for Alzheimer’s and Related Dementias

    The newly formed Center for Alzheimer’s and Related Dementias (CARD), is offering a new unique training and career development opportunity for undergraduates and recent graduates. Under a new collaborative fellowship program developed by CARD, qualified candidates will receive a remunerated full-time position to work at CARD while completing coursework to earn a paid MPS degree through partnership between the Foundation for Advanced Education in the Sciences at NIH and UMBC.

    The program aims to increase representation and inclusivity in biomedical data science and train healthcare researchers to grow their data science skills, cultivating the next generation of data science and bioinformatics professionals at CARD. Learn more at https://faes.org/CARD-FAES-UMBC_Fellowship. Please direct questions to CARD staff via email to NIAcardcontact@nih.gov.


    May 3
    Deadline for SLAM-DUNC abstract submissions. Learn more >

    May 10, 8:30 am – 12 pm
    Alzheimer’s Disease and Diabetes Symposium (online) – A Duke-UNC ADRC panel discussion will include co-directors, Heather Whitson, MD, and Gwenn Garden, MD, as panelists and Suzanne Craft, PhD, from the Wake Forest ADRC as the moderator.
    Agenda | Register >

    May 25, 11 am
    UNC BRIC Seminar Series: “Brain imaging genetics for Alzheimer’s disease: integrated analysis and machine learning”
    Li Shen, PhD, FAIMBE
    Meeting ID:942 0521 9878, Passcode: 150444

    June 24, 5 pm – 7pm; June 25, 9 am – 4:15 pm
    Symposium for Learning about Alzheimer’s disease-related Medical research at Duke and UNC (SLAM-DUNC)
    Duke Karsh Alumni and Visitors Center
    Open to researchers, clinicians, and trainees from Duke, UNC, NCCU, UNC-Pembroke, and ECU
    Learn More and Register >